PTN57491

• CAT Number: I035192
• CAS Number: 1355357-49-1
• Molecular Formula: C33H31N5O4
• Molecular Weight: 561.64
• Purity: 98%
• Synonyms: PTN57491; PTN-57491; PTN 57491; GS441524-intermediate; GS 441524-intermediate; GS-441524-intermediate; remdesivir-intermediate; Remdesivir related compound 5
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (2R,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolane-2-carbonitrile
• InChI: InChI=1S/C33H31N5O4/c34-22-33(29-17-16-27-32(35)36-23-37-38(27)29)31(41-20-26-14-8-3-9-15-26)30(40-19-25-12-6-2-7-13-25)28(42-33)21-39-18-24-10-4-1-5-11-24/h1-17,23,28,30-31H,18-21H2,(H2,35,36,37)/t28-,30-,31-,33+/m1/s1
• InChIKey: PJXBLWLWNWGFJO-TXLSGFARSA-N
• SMILES: C1=CC=C(C=C1)COC[C@@H]2[C@H]([C@H]([C@](O2)(C#N)C3=CC=C4N3N=CN=C4N)OCC5=CC=CC=C5)OCC6=CC=CC=C6

PTN57491（Cat No.:I035192）is an investigational compound being explored for its potential therapeutic effects in the treatment of autoimmune and inflammatory diseases. It is designed to modulate specific immune pathways involved in the activation of T-cells and the production of pro-inflammatory cytokines. By targeting these pathways, PTN57491 aims to reduce inflammation and prevent tissue damage in conditions such as rheumatoid arthritis and multiple sclerosis. Preclinical studies have shown promising results, but further clinical trials are needed to evaluate its safety, efficacy, and potential as a treatment for chronic autoimmune disorders.